Shopping Cart 0
Cart Subtotal
USD 0

Miraca Holdings Inc (4544) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early detection and diagnosis. Its clinical laboratory testing services include collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. Miraca Holdings provides various healthcare related services, such as sterilization, clinical trial support and preventive medicine related services. It offers sterilization services to hospitals in the Kanto, Chubu, Kansai, Chugoku and Kyushu regions. Miraca Holdings is headquartered in Tokyo, Japan.

Miraca Holdings Inc (4544)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11

Partnerships 13

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13

Baylor College to Form Joint Venture with Miraca 14

Miraca Holdings Inc-Key Competitors 15

Miraca Holdings Inc-Key Employees 16

Miraca Holdings Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Miraca Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13

Baylor College to Form Joint Venture with Miraca 14

Miraca Holdings Inc, Key Competitors 15

Miraca Holdings Inc, Key Employees 16

Miraca Holdings Inc, Subsidiaries 17

Miraca Holdings Inc, Joint Venture 17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Miraca Holdings Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Miraca Holdings Inc (Miraca Holdings) is a holding company that operates through its business segments such as clinical laboratory testing, in vitro diagnostics and healthcare segment. The company develops, manufactures and sells diagnostic products that are used in medical field for early detection and diagnosis. Its clinical laboratory testing services include collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. Miraca Holdings provides various healthcare related services, such as sterilization, clinical trial support and preventive medicine related services. It offers sterilization services to hospitals in the Kanto, Chubu, Kansai, Chugoku and Kyushu regions. Miraca Holdings is headquartered in Tokyo, Japan.

Miraca Holdings Inc (4544)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deal Details 11

Private Equity 11

Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11

Partnerships 13

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13

Baylor College to Form Joint Venture with Miraca 14

Miraca Holdings Inc-Key Competitors 15

Miraca Holdings Inc-Key Employees 16

Miraca Holdings Inc-Locations And Subsidiaries 17

Head Office 17

Other Locations & Subsidiaries 17

Joint Venture 17

Appendix 18

Methodology 18

About GlobalData 18

Contact Us 18

Disclaimer 18


List Of Figure

List of Figures

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

Miraca Holdings Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

Miraca Holdings Inc, Deals By Therapy Area, 2012 to YTD 2018 8

Miraca Holdings Inc, Medical Devices Deals, 2012 to YTD 2018 9

Miraca Holdings Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

Avista Capital Partners Acquires Miraca Life Sciences from Miraca Holdings 11

Thermo Fisher Scientific Enters Into Licensing Agreement With Fujirebio For Procalcitonin 13

Baylor College to Form Joint Venture with Miraca 14

Miraca Holdings Inc, Key Competitors 15

Miraca Holdings Inc, Key Employees 16

Miraca Holdings Inc, Subsidiaries 17

Miraca Holdings Inc, Joint Venture 17

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Miraca Holdings Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.